HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.

Abstract
Effective virus-mediated gene therapy for cancer will be facilitated by procedures that enhance the low level of gene transfer mediated by replication-deficient, recombinant viral vectors. We found recently that protease pretreatment of solid tumors is a useful strategy for enhancing virus-mediated gene transduction in vivo. In this study, we examined the potential of protease pretreatment to improve the efficacy of a gene therapy strategy for prodrug activation that depends on infection with a recombinant adenovirus encoding herpes simplex virus thymidine kinase (Ad-HSV-tk). Trypsin or a dissolved mixture of collagenase/dispase was inoculated into xenografts derived from the human glioblastoma multiforme-derived cell lines, U87 or U251. Ad-HSV-tk was administered 24 h after protease pretreatment, and animals were then treated for 10 days with ganciclovir (GCV). We found that protease pretreatment increased the efficacy of adenovirus mediated HSV-tk/GCV gene therapy in these experimental tumor models. Mice receiving Ad-HSV-tk/GCV after protease pretreatment demonstrated a significantly greater regression of tumors compared with those treated with Ad-HSV-tk/GCV alone. No adverse effects of protease pretreatment were observed. No signs of metastasis were seen either by histological inspection of lymph nodes or by a PCR-based analysis of selected mouse tissues to detect human tumor cells. Our findings indicate that protease pretreatment may be a useful strategy to enhance the efficacy of virus-mediated cancer gene therapy.
AuthorsN Kuriyama, H Kuriyama, C M Julin, K R Lamborn, M A Israel
JournalCancer research (Cancer Res) Vol. 61 Issue 5 Pg. 1805-9 (Mar 01 2001) ISSN: 0008-5472 [Print] United States
PMID11280727 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Extracellular Matrix Proteins
  • Thymidine Kinase
  • Endopeptidases
  • Trypsin
  • Collagenases
  • dispase
  • Ganciclovir
Topics
  • Adenoviridae (genetics)
  • Animals
  • Brain Neoplasms (metabolism, pathology, therapy)
  • Collagenases (metabolism, pharmacology)
  • Endopeptidases (metabolism, pharmacology)
  • Extracellular Matrix Proteins (metabolism)
  • Female
  • Ganciclovir (pharmacology)
  • Genetic Therapy (methods)
  • Genetic Vectors (genetics)
  • Glioblastoma (metabolism, pathology, therapy)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Metastasis
  • Rats
  • Rats, Inbred F344
  • Simplexvirus (enzymology, genetics)
  • Thymidine Kinase (genetics, metabolism)
  • Trypsin (metabolism, pharmacology)
  • Tumor Cells, Cultured
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: